Bristol-Myers Squibb
Bristol-Myers Squibb is a large US pharmaceutical company that develops and distributes medicines in the categories of cancer, HIV, analgesics, antibiotics, and cardiology.
2
Funding Rounds
$42.5m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Wi***** Mc***** Br***** | - | - | - |
| Jo** Ri**** My*** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| De**** W. Ri** | - | - | - |
| Ka*** Vo***** | - | - | |
| Ph***** R. Ya** | - | - | - |
| Pa*** A. Pr*** | - | - | - |
| Ge**** L. St**** | - | - | linkedin twitter |
| Ma**** Hi***** Me**** | - | - | - |
| Ju*** A. Ha**** | - | - | - |
| Th****** R. Sa***** | - | - | - |
| Gi****** Ca***** | - | - | |
| Pe*** J. Ar***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Bristol-Myers Squibb has raised a total of $42.5m in funding over 2 rounds.
Key Insights:
- Bristol-Myers Squibb Company Series C round: $15.5m
- Bristol-Myers Squibb Company Series B round: $27m
Bristol-Myers Squibb Company Series C round
$15.5m
Bristol-Myers Squibb Company Series B round
$27m
Industries
Bristol-Myers Squibb is active in the following industries:
- Pharmaceutical industry
- Internal medicine
- Allogeneic cell therapy
- Engineering
- Life science
- Healthcare
- Multiple myeloma
- Biomedical engineering
- Technology
- Immunotherapy
- Tissue engineering
- Drug discovery
- Regenerative medicine
- Genome editing
- Genomics
- Oncology
- Biology
- Digital therapeutics
- Oncolytic virus
- Biotechnology
- Therapeutics
- Biopharmaceutical
Subsidiaries
Bristol-Myers Squibb operates through the following subsidiaries:
